METHODS OF TREATMENT FOR NEUROMYELITIS OPTICA

摘要

The present disclosure relates generally to methods of preventing, reducing risk of developing, or treating neuromyelitis optica (NMO) and, more specifically, to methods involving the inhibition of the classical pathway of complement activation.